Essential thrombocythemia in a child: diagnostic and therapeutic dilemma
Saudi Medical Journal. 2005; 26 (11): 1806-1808
in English
| IMEMR
| ID: emr-74734
ABSTRACT
We report an 11-year-old child with essential thrombocythemia ET, a very rare myeloproliferative disorder among children. Essential thrombocythemia can be complicated by life-threatening thrombosis with a risk of converting into acute leukemia. Cytoreductive therapy may reduce the risk of thromboembolic complications. We usually recommend cytoreductive treatment for asymptomatic adult patients with platelet counts of more than 1.5 million/micro liter, but treatment remains obscure in children. Herein, we report the results of child with ET, treated successfully with hydroxuea
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Biopsy, Needle
/
Blood Chemical Analysis
/
Bone Marrow Cells
/
Treatment Outcome
/
Thrombocythemia, Essential
/
Hydroxyurea
Type of study:
Case report
Limits:
Humans
/
Male
Language:
English
Journal:
Saudi Med. J.
Year:
2005
Similar
MEDLINE
...
LILACS
LIS